AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 91 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,667 | -99.9% | 58 | -100.0% | 0.00% | -100.0% |
| Q2 2018 | $1,991,000 | -48.6% | 130,468 | -36.9% | 0.00% | -40.0% |
| Q1 2018 | $3,874,000 | -12.2% | 206,601 | -9.9% | 0.01% | -16.7% |
| Q4 2017 | $4,411,000 | +16.3% | 229,277 | +8.1% | 0.01% | +20.0% |
| Q3 2017 | $3,792,000 | +8.6% | 212,183 | +8.5% | 0.01% | 0.0% |
| Q2 2017 | $3,492,000 | +59.5% | 195,547 | +29.5% | 0.01% | +25.0% |
| Q1 2017 | $2,190,000 | +19.7% | 151,055 | +52.1% | 0.00% | +33.3% |
| Q4 2016 | $1,830,000 | -51.2% | 99,324 | -49.7% | 0.00% | -57.1% |
| Q3 2016 | $3,750,000 | -11.6% | 197,658 | -21.0% | 0.01% | -12.5% |
| Q2 2016 | $4,241,000 | +20.6% | 250,331 | -9.5% | 0.01% | +14.3% |
| Q1 2016 | $3,517,000 | -10.6% | 276,472 | 0.0% | 0.01% | -12.5% |
| Q4 2015 | $3,934,000 | +45.2% | 276,472 | +19.2% | 0.01% | +33.3% |
| Q3 2015 | $2,710,000 | – | 231,862 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Campbell & CO Investment Adviser LLC | 11,961 | $219,000 | 0.13% |
| FEDERATED HERMES, INC. | 3,441,367 | $63,046,000 | 0.12% |
| CORNERCAP INVESTMENT COUNSEL INC | 54,751 | $1,003,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 34,425 | $631,000 | 0.10% |
| First Trust Direct Indexing L.P. | 11,913 | $218,000 | 0.06% |
| Summit Global Investments | 47,546 | $871,000 | 0.06% |
| WINTON GROUP Ltd | 49,766 | $912,000 | 0.05% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 397,950 | $7,290,000 | 0.05% |
| AIGEN INVESTMENT MANAGEMENT, LP | 16,077 | $295,000 | 0.04% |
| EXCHANGE TRADED CONCEPTS, LLC | 52,334 | $959,000 | 0.04% |